Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.
2.
3.

Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.

Ryan JM, Schneider G, Jacobsen JS.

Alzheimers Dement. 2009 Mar;5(2):140-2. doi: 10.1016/j.jalz.2009.01.004. No abstract available.

PMID:
19328445
4.

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ.

Alzheimers Dement. 2009 Mar;5(2):85-92. doi: 10.1016/j.jalz.2009.01.021.

5.

Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging.

Petersen RC.

Alzheimers Dement. 2009 Mar;5(2):105-7. doi: 10.1016/j.jalz.2009.01.010. No abstract available.

6.

Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.

Cummings JL.

Alzheimers Dement. 2009 Mar;5(2):108-13. doi: 10.1016/j.jalz.2009.01.015. No abstract available.

PMID:
19328437
8.

Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges.

Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C.

Alzheimers Dement. 2009 Mar;5(2):166-71. doi: 10.1016/j.jalz.2008.12.002. Review. No abstract available.

9.
10.

Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?

Gauthier S, Poirier J.

Alzheimers Dement. 2009 Mar;5(2):147-8. doi: 10.1016/j.jalz.2009.01.007. No abstract available.

PMID:
19328447
11.
12.

Commentary on "a roadmap for the prevention of dementia II: Leon Thal symposium 2008." The megacommunity approach to Alzheimer's disease.

Van Lee R, Meagher B, Fritz P, Penfield S.

Alzheimers Dement. 2009 Mar;5(2):163-5. doi: 10.1016/j.jalz.2009.02.002.

PMID:
19328452
14.
15.
16.

Prevent Alzheimer's disease by 2020: a national strategic goal.

Khachaturian ZS, Khachaturian AS.

Alzheimers Dement. 2009 Mar;5(2):81-4. doi: 10.1016/j.jalz.2009.01.022. No abstract available.

PMID:
19328433
17.
18.

Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad.

Korczyn AD.

Alzheimers Dement. 2009 Mar;5(2):157-8. doi: 10.1016/j.jalz.2009.01.009. No abstract available.

PMID:
19328450
19.

Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.

Petanceska S, Ryan L, Silverberg N, Buckholtz N.

Alzheimers Dement. 2009 Mar;5(2):130-2. doi: 10.1016/j.jalz.2009.01.014. Review. No abstract available.

PMID:
19328442
20.

Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.

Foster NL, Andersen TC, Zamrini EY.

Alzheimers Dement. 2009 Mar;5(2):159-62. doi: 10.1016/j.jalz.2009.01.017.

PMID:
19328451

Supplemental Content

Support Center